Lumicks Technologies is a revenue stage life sciences tools company. The company was founded in 2014 as a spin-off from the Vrije Universiteit Amsterdam. Lumicks is the leading supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments. The instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Lumicks developed two commercial business lines:

–        The C-Trap is the first integrated correlative tweezers-fluorescence system for real-time manipulation and visualization of interactions at the single-molecule level (Dynamic Single-Molecule analysis).

–        The Z-Movi enables automated screening and sorting of T-cells based on Cell Avidity measurements.

The total addressable market of C-Trap and Z-Movi combined exceeds $10B and grows at more than 10% CAGR. Gilde acted as sole institutional investor supporting Lumicks in all financing rounds starting at seed phase.